PSP ETF

The company reported positive results from the phase 2 HELIOS study of AMX0035 for Wolfram Syndrome, setting up initiation of a potential phase 3 trial in 2025. An interim analysis of the phase 2b/3 ORION trial for Progressive Supranuclear Palsy is expected in mid-2025, determining the program's future. Financially, Amylyx has $234.4 million in cash, enough to fund operations into 2026, but may need to raise additional funds in 2025.

The Invesco Global Listed Private Equity ETF offers exposure to the private markets industry via publicly traded vehicles. PSP has delivered relatively weak historical performance for investors relative to the broader market. The ETF is highly diversified and includes significant exposure to BDCs.

Investment Highlights Capital investment of $40 million for acquisition of PSP Products, Inc., which offers a diverse line of surge protection devices and industry leading load management systems Valuation represents approximately 5.0x PSP Products' trailing twelve-months' EBITDA Expected to be accretive to earnings per share in the first full year of ownership $647MM of cumulative acquisition capital investment since going public in October 2015 DALLAS, Aug. 06, 2024 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (Nasdaq: CSWI) today announced the strategic acquisition of PSP Products, Inc. (“PSP”), deploying $40 million. This acquisition further demonstrates the Company's commitment to allocate capital to leverage our powerful HVAC/R distribution channel to extend our offering of products to our customers.

Investing in public stocks of private equity firms can generate significant returns and benefit from professional management and strategic insights. The Invesco Global Listed Private Equity ETF allows investors to access the private equity sector and holds a diverse range of private equity firms. PSP has a large allocation to the financial sector and carries risks inherent to private equity investments, but can provide diversification benefits and potential relative strength against the sector.

This thesis aims to address the needs of investors looking to diversify beyond equities and bonds. In this case private equity in the form of the PSP ETF represents a suitable alternative investment. For this matter, it is important to elaborate on the risks associated with PE especially given that both Warren Buffett and Charlie Munger are against investing in alternatives.

PSP is not particularly discounted despite dangers to PE balance sheets. Higher for longer could mean impairments coming in, especially for those massive 2021 outlays that are going to be benefiting from no multiple effects and may have exposure to rates. While debt arrangements may make a somewhat safe deleveraging possible, it's unclear given NAV-related loans and reports of some financial concerns.